5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240231, 화합물
반응식
[CH:1]([C:4]1[CH:5]=[C:6](B2OC(C)(C)C(C)(C)O2)[CH:7]=[CH:8][CH:9]=1)([CH3:3])[CH3:2].[Cl:19][C:20]1[CH:21]=[C:22]([CH2:26][N:27]2[CH:31]=[CH:30][N:29]=[C:28]2[CH3:32])[N:23]=[N:24][CH:25]=1>>[ClH:19].[CH:1]([C:4]1[CH:9]=[C:8]([C:20]2[CH:21]=[C:22]([CH2:26][N:27]3[CH:31]=[CH:30][N:29]=[C:28]3[CH3:32])[N:23]=[N:24][CH:25]=2)[CH:7]=[CH:6][CH:5]=1)([CH3:3])[CH3:2]참가 물질
3
실험 절차
The title compound, MS: m/e=293.3 (M+H+), was prepared from 2-(3-isopropyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
출처 및 근거
- ORD 기록
- ord-60e7062341774d519f65cb111f4a21d5
- 출처 데이터셋
- uspto-grants-2006_02
- 특허 번호
- US07005432B2
반응 노트
불러오는 중…